Volpara Health

The countdown is on until RSNA 2024! We can’t wait to connect with our customers and peers from around the world to talk strategy, challenges, and opportunities. Let’s dive into how we can advance early cancer detection through AI and automated solutions. Partner with us and experience the reliability and safety of a team backed by 400+ peer-reviewed papers, trusted by 7,000 facilities, and committed to the success of your entire program—not just the technology. Come visit us at RSNA 2024. Reserve your appointment now: info.volparahealth.com/rsna24 We’re here to collaborate and support your journey.

Make 2025 the year you improve how you identify and manage high-risk patients. @RushUniversity did: "We have a 56-year-old patient whose life was changed by understanding her risk and getting access to additional imagining beyond her annual mammogram." volparahealth.com/news/customer-…

Is improving clinical decision-making on your 2025 resolutions list? Volpara Scorecard™ will give your team: ✅ Key breast density and risk insights in one view. ✅ Science-based data and alerts when patients meet high-risk thresholds. volparahealth.com/breast-health-…

"Prior to Volpara's EQUIP reports, I was spending hours collecting data. Now I can spend time improving quality. My experience with this has been wonderful." - @OaklawnCares Looking to improve your program performance? Learn how: volparahealth.com/breast-health-…

“The key is to help technologists not fear AI but to embrace it as a partner.” 💡 That’s how @UofR achieved its mammography quality goals across 12 imaging sites, a mobile van, and 40 technologists. Learn how: volparahealth.com/news/customer-…

@TheImagingWire explored the impact of AI (and, more specifically, Lunit’s AI) on improving accuracy, reducing radiologist workload, and fine-tuning algorithms for better performance. Learn how AI is shaping the future of breast cancer screening: theimagingwire.com/newsletter/fin…

Think your eyes can beat @Lunit_AI? 🤔 Test yourself compared to Lunit INSIGHT for Breast via an interactive challenge experience. Let us know your results in the comments. 👇 insight-challenge.lunit.io

As the year draws to a close, I wanted to extend warm holiday wishes from Volpara Health to you. Just as the holiday season is about giving, let's unwrap the potential for a prosperous partnership in 2025 that brings abundant benefits to your patients.

Over 25% of patients at @RushUniversity Medical Center are flagged as high-risk for breast cancer—thanks to Volpara® Risk Pathways™. In just two years, 69% of high-risk patients met NCCN Guidelines® for follow-up, leading to improved outcomes. volparahealth.com/news/customer-…

In just 24 months, @mySingingRiver achieved: ✔️ 25% of patients met NCCN Guidelines® for genetic testing. ✔️ 36% completed the test onsite, identifying 6% with pathogenic mutations or carrier status. ✔️ 42% received negative genetic results Learn more: volparahealth.com/news/customer-…

Will 2025 be the year you make smarter, more personalized breast care a priority in your organization? Our breast screening software is designed to support your efforts. Let’s start the new year strong—request a demo: volparahealth.com/volpara/contac…

@MemoiralCareHS, a participant in the ACR collective, improved mammography metrics from 92% to 96% in six months, reduced variability by 20%, and boosted quality by 13%—all while sustaining excellence with Volpara Analytics. Read the full case study: volparahealth.com/news/how-memor…

SecondRead AI is a second set of eyes that gives radiologists AND patients peace of mind.  👀 Watch this quick, real-world use case that led to the discovery and confirmation of a high-risk lesion: vimeo.com/1016247598/f3b…

Big news! Lunit and Rezolut have launched SecondReadAI, an innovative AI-powered tool that provides a second opinion on mammograms. It helps spot subtle details that could be missed and boosts early-stage cancer detection by up to 15%! Learn more: vimeo.com/1016301782/adc…

Just got back from RSNA, and wow—it was a whirlwind! 🩷 This year marked a big milestone—our first event with @Lunit_AI since joining forces. Together, we unveiled how our combined expertise will shape the future of breast cancer diagnostics. koreabiomed.com/news/articleVi…

"Radiologists used to read images on their own?!" 😱 At RSNA, our CEO Teri Thomas spoke with @MedCityNews about how Volpara and @Lunit_AI are shaping the future of mammography with AI—bringing smarter tools and sharper insights to radiology. medcitynews.com/2024/12/why-on…

🚨 Lunit AI was highlighted yesterday during @TheImagingWire Show! Learn from @UCDavisHealth and Mosaic Breast Imaging as they share insights and their experience using @Lunit_AI's AI technology to improve cancer detection. youtube.com/watch?v=Ybu0vM…

Between 2020–2023, nearly 26% of @RushMedical's patients were flagged as an elevated risk, enabling personalized surveillance with advanced imaging options like ABUS and Fast MRI. Learn how Rush uses our tech to ensure tailored care: volparahealth.com/news/customer-…

The @UofR is setting the bar high in mammography quality! 📈 Volpara Analytics™ helped them reduce technical repeat rates to as low as 1-2% and foster a culture of recognition and improvement among their 40+ technologists. volparahealth.com/news/customer-…

RSNA is about more than tech—it's about finding partners dedicated to your success! 💡 Look for: 🌱 Customer success managers 🌱 Pro services for smooth implementation 🌱 Online communities & learning tools Reserve your spot now: volparahealth.com/volpara-health… #RSNA2024 #RadiologyInnovation

ICYMI: Our new contract with the U.S. Defense Health Agency will enhance screening services for 9.6 million active-duty members, veterans, and their families! 🎉 prnewswire.com/news-releases/…